How beneficial is noninvasive ventilation in patients with amyotrophic lateral sclerosis? Commentary

Nature Clinical Practice Neurology

Volumn 2, Issue 7, 2006, Pages 356-357

  Lechtzin, Noah ^a,b  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Amyotrophic lateral sclerosis; Noninvasive ventilation; Quality of life; Sleep related symptoms; Survival

Indexed keywords

RILUZOLE;

AMYOTROPHIC LATERAL SCLEROSIS; ARTIFICIAL VENTILATION; CLINICAL TRIAL; HUMAN; HYPERCAPNIA; LUNG FUNCTION TEST; MORTALITY; NON INVASIVE PROCEDURE; PATIENT CARE; PRIORITY JOURNAL; QUALITY OF LIFE; RESPIRATORY FAILURE; SHORT FORM 36; SHORT SURVEY; STATISTICAL SIGNIFICANCE; SURVIVAL; SURVIVAL TIME; TREATMENT OUTCOME; TREATMENT RESPONSE;

AMYOTROPHIC LATERAL SCLEROSIS; HUMANS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIALS; RESPIRATION, ARTIFICIAL; RESPIRATORY MECHANICS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 33745602742     PISSN: 1745834X     EISSN: 17458358     Source Type: Journal    
DOI: 10.1038/ncpneuro0217     Document Type: Short Survey

References (3)

1. Bensimon G et al. (1994) A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group. N Engl J Med 330: 585-591
2. Bourke SC and Gibson GJ (2004) Non-invasive ventilation in ALS: Current practice and future role. Amyotroph Lateral Scler Other Motor Neuron Disord 5: 67-71
3. Miller RG et al. (1999) Practice parameter: The care of the patient with amyotrophic lateral sclerosis (an evidence-based review). Muscle Nerve 22: 1104-1118